The performance of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key territories has introduced significant volatility. Investors are now grappling with the consequences of